Defensin beta 3 Antikörper
Kurzübersicht für Defensin beta 3 Antikörper (ABIN2766518)
Target
Alle Defensin beta 3 (DEFB3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Ion exchange
-
Immunogen
- r.Human beta-defensin-3
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Direct ELISA, Immuneprecipitation, blotting , Immunohistochemistry. By direct ELISA, 1:7,000 dilution will yield 0.4 O.D using alkaline phosphatase conjugated rabbit anti-mouse Ig (Jackson Laboratories).
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Rekonstitution
- Reconstitute with H20. Mix gently, wash the sides of the vial and wait 30-60 seconds before use. Recommended
-
Buffer
- 1 mg/mL in PBS (after reconstitution).
-
Lagerung
- -20 °C
-
-
-
: "Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells." in: Virology, Vol. 487, pp. 172-87, (2016) (PubMed).
-
: "Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells." in: Virology, Vol. 487, pp. 172-87, (2016) (PubMed).
-
- Defensin beta 3 (DEFB3)
-
Andere Bezeichnung
- beta Defensin-3
-
Hintergrund
- Synonyms: HBD3, HBP3, DEFB3, HBD-3, HBP-3, DEFB103.
-
Pathways
- Production of Molecular Mediator of Immune Response
Target
-